The Scientist

» products and disease/medicine

Most Recent

image: Signs of Neuro-problems?

Signs of Neuro-problems?

By | February 17, 2012

The likelihood of developing dementia later in life may be predicted by the speed at which people walk, while grip strength may predict stroke.

2 Comments

image: Propitious Prions

Propitious Prions

By | February 15, 2012

Often thought to be artifacts of the lab, prions in yeast may actually drive the evolution of beneficial traits.

0 Comments

image: Social Media for Epidemiology?

Social Media for Epidemiology?

By | February 14, 2012

Epidemiologists consider how social media could be harnessed to predict disease outbreaks.

4 Comments

image: FDA's Biosimilars Guidance

FDA's Biosimilars Guidance

By | February 13, 2012

The federal agency finally breaks out some information on what it might take to get generic biological drugs approved.

3 Comments

image: Cancer’s First Step

Cancer’s First Step

By | February 8, 2012

A single mutant cell breaks free of its neighbors in the early stages of cancer development.

7 Comments

image: Komen’s Second Funding Debate

Komen’s Second Funding Debate

By | February 8, 2012

The cancer charity is embroiled in an argument over embryonic stem cell research.

18 Comments

image: <em>C. diff</em> Infection Source Unclear

C. diff Infection Source Unclear

By | February 7, 2012

Only a quarter of Clostridium difficile infections in one hospital system were traced to contact with a symptomatic patient.

15 Comments

image: Novel Cystic Fibrosis Drug Approved

Novel Cystic Fibrosis Drug Approved

By | February 1, 2012

After a lightning-fast approval, the first medicine to treat an underlying cause of the disorder hits the market.

0 Comments

image: Calcium and the Pancreas

Calcium and the Pancreas

By | February 1, 2012

Normal pancreatic function depends on the precise flow of calcium within and into the acinar cells of the organ. 

0 Comments

image: Switching the Bait

Switching the Bait

By | February 1, 2012

Turning a standard technique into an unbiased screen for diagnostic biomarkers

6 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech